Affiliation:
1. Fujian Medical University
2. The First Affiliated Hospital of Xiamen University, Xiamen University
Abstract
Abstract
Background
The risk factors for spinal stenosis are unclear. During this research, we conducted an exploration of the causal relationships between primary hypertension, triglycerides, insomnia, and spinal stenosis in European-origin patients.
Methods
Genome-wide association study data from large sample projects related to our reaserch were downloaded from the IEU OpenGWAS Project. These data relate mainly to the following characteristics: primary hypertension, insomnia, triglycerides, and spinal stenosis. Spinal stenosis was taken as the consequence and the three other features as the exposure. The analyses were conducted with single and multivariate Mendelian randomization (MR). The inverse-variance weighted (IVW) MR served as the primary measure of analysis. To test the stability and reliability of causal estimates, we conducted a variety of sensitivity tests, which included consistent, heterogenicity, and pleiotropy analyses.
Results
According to the IVW results of MR univariate analysis, spinal stenosis risk is higher in patients with primary hypertension (odds ratio (OR): 1.0124; 95% confidence interval (CI): 1.0036–1.0213; P value: 5.49×10 − 3), insomnia (OR: 1.0062; 95% CI: 1.0008–1.0116; P value: 0.023), and triglycerides (OR: 1.0012; 95% CI: 1.0003–1.0021; P value: 0.004). However, multivariable MR analysis indicated triglycerides (OR: 1.0010; 95% CI: 1.0001–1.0019; P value: 0.018) had an independent causal relationship with spinal stenosis risks.
Conclusion
This study indicated the effect of primary hypertension, triglycerides, and insomnia on spinal stenosis risks.
Publisher
Research Square Platform LLC
Reference24 articles.
1. Munakomi S, Foris LA, Varacallo M, Spinal Stenosis and Neurogenic Claudication. 2023 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 28613622.
2. Lumbar spinal stenosis;Ciricillo SF;West J Med,1993
3. Marcolina A, Vu K, Annaswamy TM. Lumbar Spinal Stenosis and Potential Management With Prostaglandin E1 Analogs. Am J Phys Med Rehabil. 2021;100(3):297–302. doi: 10.1097/PHM.0000000000001620. PMID: 33065578.
4. Evaluating the causal relationship between five modifiable factors and the risk of spinal stenosis: a multivariable Mendelian randomization analysis;Wan B;PeerJ,2023
5. Bagley C, MacAllister M, Dosselman L, Moreno J, Aoun SG, El Ahmadieh TY. Current concepts and recent advances in understanding and managing lumbar spine stenosis. F1000Res. 2019;8:F1000 Faculty Rev-137. doi: 10.12688/f1000research.16082.1. PMID: 30774933; PMCID: PMC6357993.